Spinal muscular atrophy (SMA) is characterized by degeneration of motor neurons of the spinal cord associated with muscle paralysis and caused by mutations of the survival motor neuron gene (SMN). To determine whether SMN gene defect in skeletal muscle might have a role in SMA pathogenesis, deletion of murine SMN exon 7, the most frequent mutation found in SMA, has been restricted to skeletal muscle by using the Cre-loxP system. Mutant mice display ongoing muscle necrosis with a dystrophic phenotype leading to muscle paralysis and death. The dystrophic phenotype is associated with elevated levels of creatine kinase activity, Evans blue dye uptake into muscle fibers, reduced amount of dystrophin and upregulation of utrophin expression suggesting a destabilization of the sarcolemma components. The mutant mice will be a valuable model for elucidating the underlying mechanism. Moreover, our results suggest a primary involvement of skeletal muscle in human SMA, which may contribute to motor defect in addition to muscle denervation caused by the motor neuron degeneration. These data may have important implications for the development of therapeutic strategies in SMA.
Skip Nav Destination
Article navigation
5 March 2001
Article Contents
Report|
March 05 2001
Deletion of Murine SMN Exon 7 Directed to Skeletal Muscle Leads to Severe Muscular Dystrophy
Carmen Cifuentes-Diaz,
Carmen Cifuentes-Diaz
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Tony Frugier,
Tony Frugier
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Francesco D. Tiziano,
Francesco D. Tiziano
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Emmanuelle Lacène,
Emmanuelle Lacène
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Natacha Roblot,
Natacha Roblot
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Vandana Joshi,
Vandana Joshi
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Marie Helene Moreau,
Marie Helene Moreau
bLaboratoire de Biologie Clinique, Centre Hospitalier Sud-Francilien, 91014 Evry, France
Search for other works by this author on:
Judith Melki
Judith Melki
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Search for other works by this author on:
Carmen Cifuentes-Diaz
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Tony Frugier
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Francesco D. Tiziano
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Emmanuelle Lacène
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Natacha Roblot
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Vandana Joshi
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Marie Helene Moreau
bLaboratoire de Biologie Clinique, Centre Hospitalier Sud-Francilien, 91014 Evry, France
Judith Melki
aMolecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, EMI-9913, Genopole, 91057 Evry, France
Carmen Cifuentes-Diaz and Tony Frugier contributed equally to this work.
Abbreviations used in this paper: AChR, acetylcholine receptor, ChAT, choline acetyl transferase; CK, creatine kinase; DGC, dystrophin–glycoprotein complex; EBD, Evans blue dye; SMA, spinal muscular atrophy; SMN, survival motor neuron; RT, reverse transcription; U snRNP, uridine-rich small ribonucleoprotein.
Received:
September 26 2000
Revision Requested:
January 17 2001
Accepted:
January 22 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 152 (5): 1107–1114.
Article history
Received:
September 26 2000
Revision Requested:
January 17 2001
Accepted:
January 22 2001
Citation
Carmen Cifuentes-Diaz, Tony Frugier, Francesco D. Tiziano, Emmanuelle Lacène, Natacha Roblot, Vandana Joshi, Marie Helene Moreau, Judith Melki; Deletion of Murine SMN Exon 7 Directed to Skeletal Muscle Leads to Severe Muscular Dystrophy. J Cell Biol 5 March 2001; 152 (5): 1107–1114. doi: https://doi.org/10.1083/jcb.152.5.1107
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
